Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECALL long-term follow-up of BeSt and IMPROVED
NL-OMON52763Completed
- Sponsor
- Leiden University Medical Center
- Start
- May 2019
- Countries
- 1
01
Overview
Open-label trial in rheumatoid arthritis (RA) and undifferentiated arthritis (UA) (2 cohorts), sponsored by Leiden University Medical Center. Primary endpoints: Radiographic joint damage progression, Functional decline and 1 more. Started May 2019; status: completed.
02
Conditions
rheumatoid arthritis (RA)undifferentiated arthritis (UA)
Beyond the preview
Go deeper on NL-OMON52763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52763.